NASDAQ: SNSE - Sensei Biotherapeutics, Inc.

Lønnsomhet i seks måneder: -15%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Sensei Biotherapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors.

flere detaljer
It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2021-02-04
ISIN US81728A1088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.senseibio.com
Цена ао 0.436
Prisendring per dag: +17.99% (0.4308)
Prisendring per uke: +3.73% (0.49)
Prisendring per måned: +12.23% (0.4529)
Prisendring over 3 måneder: +2.07% (0.498)
Prisendring over seks måneder: -15% (0.598)
Prisendring per år: -51.59% (1.05)
Prisendring over 3 år: -80.07% (2.55)
Prisendring siden begynnelsen av året: +4.89% (0.4846)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 0.2886 10
P/E 0 0
EV/EBITDA -0.3268 0
Total: 3.75

Effektivitet

Navn Betydning Karakter
ROA, % -45.85 0
ROE, % -52.55 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.1701 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 169.24 10
Lønnsomhet EPS, % -20.78 0
Total: 5.6
Flere detaljer

Institusjoner Volum Dele, %
Newtyn Management, LLC 1572023 6.27
Vanguard Group Inc 573651 2.29
Renaissance Technologies, LLC 143508 0.57
Geode Capital Management, LLC 136318 0.54
Bridgeway Capital Management, Inc. 112900 0.45
Duquesne Family Office LLC 100000 0.4
Bank of America Corporation 90788 0.36
Millennium Management LLC 38295 0.15
Blackrock Inc. 34813 0.14
Northern Trust Corporation 26049 0.1



Veileder Stillingstittel Betaling Fødselsår
Mr. John K. Celebi M.B.A. President, CEO & Director 882.28k 1972 (53 år)
Dr. Edward Van der Horst Ph.D. Chief Scientific Officer 630.81k 1974 (51 år)
Ms. Lora Pike Vice President of Investor Relations & Communications N/A
Mr. Christopher W. Gerry J.D. Senior VP, General Counsel & Secretary N/A
Ms. Stephanie Krebs M.B.A., M.S. Chief Business Officer N/A 1978 (47 år)
Dr. Aaron Weitzman FACP, M.D., Ph.D. Chief Medical Officer N/A
Mr. Josiah Craver Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer

Adresse: United States, Rockville. MD, 1405 Research Boulevard - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.senseibio.com